Ben O'Leary
Clinician Scientist & Honorary Consultant in Clinical Oncology,
The Institute of Cancer Research & The Royal Marsden Hospital
Ben is a Clinician Scientist and Honorary Consultant in Clinical Oncology at The Institute of Cancer Research and The Royal Marsden and a visiting scientist in Peter Van Loo's Cancer Genomics group at The MD Anderson Cancer Center in Texas. His research is focused on understanding the evolution of resistance to cancer therapies in breast and head and neck cancers, including the use of liquid biopsies. He leads a number of translational studies at The Institute of Cancer Research and The Royal Marsden.
Sessions
-
21-May-2024Keynote Theatre | Early Diagnosis and Screening Focus DayDebate: Would you want to know? The dilemma of cancer blood testing
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
){kind=logo}
){kind=logo}
.jpg/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
